I watched a young woman’s chest for any movement. The author recounted this scene from an ICU apnea test used to determine brain death. The patient, a 22-year-old with catastrophic brain injury, never breathed again once the ventilator was briefly withdrawn; the diagnosis met the three standard clinical criteria that clinicians use. The author described the later letter his team received: four lives preserved by that donation. Kidneys, liver, heart—recipients now doing quotidian things the donor’s family could not imagine in those early hours. He wrote that he strongly supports organ donation, even as he questions process changes that may shift when families are approached.
The Uniform Determination of Death Act provides two legal pathways to declare death: irreversible cessation of circulatory and respiratory function, or irreversible loss of whole-brain function. Clinicians use a third-pronged clinical examination for brain death: a known cause of coma, absent brainstem reflexes, and failure to breathe on an apnea test. The author emphasized that patients diagnosed correctly with brain death have never recovered. Still, families struggle. A body on a ventilator seems alive—warm skin, steady cardiac activity—and that appearance complicates consent conversations.
In 2025 the Department of Health and Human Services reported 73 instances where donation was authorized but not completed and where donors showed “neurological signs incompatible with organ donation,” the author noted. A New York Times investigation, cited in the piece, found cases suggesting that organ procurement sometimes began before clear confirmation of death, particularly in rural or smaller hospitals. Those findings raised concerns that urgency to increase transplant numbers might eclipse careful neurological assessment.
The piece summarized a policy change from the Organ Procurement and Transplantation Network that will permit organ procurement organizations to approach families about donation before a decision has been made to withdraw life-sustaining treatment. The stated goal of the change is to increase the supply of viable organs for the more than 100,000 people on waiting lists. The author argued this timing risks blurring two distinct roles: the clinicians trying to determine prognosis and provide care, and procurement teams focused on organ recovery.
He warned that introducing donation discussions early could erode trust. Families expect the ICU team’s primary commitment to be their loved one’s welfare. Interruption of delicate conversations about prognosis and treatment withdrawal by donation staff—often when families have not yet accepted the imminence of death—may generate suspicion about the motives of treating teams.
The source did not provide granular operational details of the new policy, such as exact timing windows for approaches, scripted language for donation requests, or mandated structural safeguards to preserve separation between treating clinicians and procurement personnel. Those specifics remain absent from the article.
The author proposed concrete alternatives to protect families while maintaining donation rates. First, he urged better public education so that when people check “organ donor” they understand legal definitions of death and the practical differences between DCD and brain death. Second, he recommended expanding access to neurological expertise in underserved settings: video consultations with neurologists or neurointensivists could support assessment of consciousness and prognosis in small or rural hospitals before operating rooms are prepared for donation after circulatory death. Third, the author suggested prioritizing donation from patients already declared brain dead, where standardized examination protocols and a clear time window reduce the chance of premature procurement and provide families time to grieve and consent.
He emphasized that ICU teams should remain clear about their primary duty to the patient and that organ procurement teams should remain functionally independent during end-of-life decision-making. The author used the phrase “we continue to care for our patients” to stress that withdrawing life support is not abandonment but a different form of care for dying patients.
The new policy takes effect Nov. 18, the source noted. That date creates an immediate need for operational guidance. The article raised, but did not answer, several policy questions: how will independence between treating clinicians and procurement organizations be enforced in practice; what safeguards will prevent early approaches from influencing clinical decisions about withdrawal; and how will rural hospitals be supported to ensure accurate neurological evaluation prior to any organ recovery?
The author closed by reiterating his support for donation alongside his call for careful safeguards. He recommended education, tele-neurology access, and a focus on post–brain-death donation as practical steps. The piece ends on unresolved issues and the policy effective date rather than a broad, synthetic conclusion, leaving clear questions about implementation, oversight, and family trust that the article itself did not resolve.